ADRI Research recognised by award at WIN Symposium

The research leading to ADRI’s upcoming clinical trial has been recognised by the award of one of two best poster prizes at the recent WIN Symposium 2014 in Paris. The study describes the translational research leading to the new microRNA-based treatment approach for malignant pleural mesothelioma and non-small cell lung cancer, and was presented by Dr Glen Reid. The WIN symposium, with the theme this year of “WINning combinations for precision cancer medicine” had 400 delegates from around the world, and focused on breakthrough biomarker investigations and combined therapeutic approaches.